[-] Show simple item record

dc.contributor.authorBoyle, Gingereng
dc.contributor.authorMounsey, Anne L.eng
dc.contributor.authorCrowell, Kareneng
dc.date.issued2009eng
dc.description.abstractErythromycin has a limited role in treating pediatric patients (strength of recommendation [SOR]: B, limited-quality, patient-oriented evidence). Tegaserod and cisapride are the only prokinetic agents available for constipated adults (SOR: A, consistent, good-quality, patient-oriented evidence for tegaserod; SOR: B, for cisapride), but cardiovascular risk restricts prescribing of both medications.eng
dc.identifier.urihttp://hdl.handle.net/10355/3897eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2009 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 58, no. 04 (April 2009): 220d-220f.eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectintestinal contractionseng
dc.subjectirritable bowel syndromeeng
dc.subjectcardiac arrhythmiaeng
dc.subject.lcshConstipation -- Treatmenteng
dc.subject.lcshErythromycin -- Effectivenesseng
dc.subject.lcshConstipation in children -- Treatmenteng
dc.subject.lcshCisapride -- Effectivenesseng
dc.titleWhat is the role of prokinetic agents for constipation?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record